Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Profit After Tax (2016 - 2025)

Traws Pharma's Profit After Tax history spans 14 years, with the latest figure at -$7.4 million for Q4 2025.

  • Quarterly results put Profit After Tax at -$7.4 million for Q4 2025, up 75.13% from a year ago — trailing twelve months through Dec 2025 was $9.2 million (up 105.51% YoY), and the annual figure for FY2025 was $9.2 million, up 105.51%.
  • Profit After Tax for Q4 2025 was -$7.4 million at Traws Pharma, down from -$4.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $21.5 million in Q1 2025 to a low of -$123.1 million in Q2 2024.
  • The 5-year median for Profit After Tax is -$4.5 million (2021), against an average of -$10.6 million.
  • The sharpest move saw Profit After Tax tumbled 2797.48% in 2024, then surged 531.27% in 2025.
  • Year by year, Profit After Tax stood at -$3.8 million in 2021, then tumbled by 44.0% to -$5.4 million in 2022, then increased by 22.8% to -$4.2 million in 2023, then crashed by 615.15% to -$29.9 million in 2024, then skyrocketed by 75.13% to -$7.4 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$7.4 million, -$4.0 million, and -$915000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.